INSPIRE MEDICAL Aktie

>INSPIRE MEDICAL Aktienkurs

70.3 EUR -3.1% (Tradegate)

Ask: 71.48 EUR / 83 Stück

Bid: 69.96 EUR / 85 Stück

Tagesumsatz: 421 Stück

Realtime Kurs von 7:30 bis 22 Uhr!

Aktie über LYNX handeln

Intraday

1 Jahr

>INSPIRE MEDICAL Performance

1 Woche: +11,5%

1 Monat: +6,9%

3 Monate: +4,7%

6 Monate: -51,6%

1 Jahr: -62,1%

laufendes Jahr: -61,1%

>INSPIRE MEDICAL Aktie

Name:

INSPIRE MEDICAL SYSTEMS

Land:

USA

Sektor:

Gesundheit

ISIN/ Wkn:

US4577301090 / A2JLEP

Symbol/ Ticker:

2DR (Frankfurt) / INSP (NYSE)

Kürzel:

FRA:2DR, ETR:2DR, 2DR:GR, NYSE:INSP

Index:

Webseite:

https://www.inspiresleep...

Profil:

Inspire Medical Systems, Inc. is a pioneering comp..
>Volltext..

Marktkapitalisierung:

2105.31 Mio. EUR

Unternehmenswert:

1858.61 Mio. EUR

Umsatz:

763.05 Mio. EUR

EBITDA:

42.66 Mio. EUR

Nettogewinn:

38.52 Mio. EUR

Gewinn je Aktie:

1.3 EUR

Schulden:

28.16 Mio. EUR

Liquide Mittel:

97.56 Mio. EUR

Operativer Cashflow:

115.58 Mio. EUR

Bargeldquote:

2.91

Umsatzwachstum:

10.84%

Gewinnwachstum:

27.92%

Dividende je Aktie:

Dividendenrendite:

Dividendenschätzung:

Insiderhandel:

Suchwörter:

INSPIRE MEDICAL

Letzte Datenerhebung:

08.11.25

>Kennzahlen

Aktien/ Unternehmen:

Aktien: 29.06 Mio. St.

Frei handelbar: 90.4%

Leerverk. Aktien: 9.57%

Rückkaufquote: 7.67%

Mitarbeiter: 1246

Umsatz/Mitarb.: 0.56 Mio. EUR

Analysten:

Analystenrating: Buy

Kursziel: 21.03%

Bewertung:

KGV: 60.81

KGV lG: 56.46

KUV: 2.72

KBV: 3.87

PEG-Ratio: 1.57

EV/EBITDA: 43.57

Rentabilität:

Bruttomarge: 84.92%

Gewinnmarge: 5.05%

Operative Marge: 4.16%

Managementeffizenz:

Gesamtkaprendite: 5.56%

Eigenkaprendite: 6.54%

>Peer Group

Es sind 597 Aktien bekannt.

>INSPIRE MEDICAL Chart & Kurs - NYSE

>INSPIRE MEDICAL News

08.11.25 - 23:06	INSP Investors Have Opportunity to Lead Inspire Medical Systems, Inc. Securities Fraud Lawsuit (PR Newswire)
	NEW YORK, Nov. 8, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Inspire Medical Systems, Inc. (NYSE: INSP) between August 6, 2024 and August 4, 2025, both dates inclusive (the "Class......

07.11.25 - 23:54	Stockholder Alert: Robbins LLP Informs Investors of the Inspire Medical Systems, Inc. Class Action Lawsuit (PR Newswire)
	SAN DIEGO, Nov. 7, 2025 /PRNewswire/ -- Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Inspire Medical Systems, Inc. (NYSE: INSP) common stock between August 6, 2024 and August 4, 2025. Inspire is a medical......

04.11.25 - 20:30	INSP Stock Gains Following Q3 Earnings Beat, Gross Margin Expands (Zacks)
	Inspire Medical tops third-quarter 2025 estimates as revenue climbs and gross margin improves, with full-year EPS guidance raised....

04.11.25 - 13:03	Inspire Medical Systems signals 10–11% revenue growth for 2026 while reaffirming $900M–$910M guidance for 2025 (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

04.11.25 - 01:00	Inspire Medical (INSP) Q3 2025 Earnings Transcript (Fool)
	Um den gesamten Artikel unter fool.com zu lesen, klicken Sie bitte auf die Überschrift...

03.11.25 - 22:09	Inspire Medical Systems Non-GAAP EPS of $0.38 beats by $0.55, revenue of $224.5M beats by $4.11M (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

03.11.25 - 22:06	Inspire Medical Systems, Inc. Announces Third Quarter 2025 Financial Results and Updates 2025 Outlook (GlobeNewswire EN)
	MINNEAPOLIS, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire, or the company), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, today reported financial results for the quarter ended September 30, 2025....

27.10.25 - 13:03	Inspire Medical Systems, Inc. to Present at the 2025 UBS Global Healthcare Conference (GlobeNewswire EN)
	MINNEAPOLIS, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the 2025 UBS Global Healthcare Conference on Monday, November 10, 2025....

24.10.25 - 18:42	Inspire Medical cut at Jefferies on GLP-1 uptake, potential rivalry (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

24.10.25 - 15:51	Analyst Expectations For Inspire Medical Systems′s Future (Benzinga)
	Latest Ratings for INSP DateFirmActionFromTo Feb 2022SVB LeerinkMaintainsOutperform Nov 2021Piper SandlerMaintainsOverweight Nov 2021Wells FargoMaintainsOverweight View More Analyst Ratings for INSP View the Latest Analyst Ratings read more...

13.10.25 - 20:30	INSP Shares Down Despite Strong Clinical Data From Inspire V Trials (Zacks)
	Inspire Medical's Inspire V system shows strong safety, faster surgeries, and higher patient adherence in new trials....

10.10.25 - 13:03

Inspire Medical Systems, Inc. Publishes Inspire V Data at ISSS/AAO-HNS Meetings (GlobeNewswire EN)

MINNEAPOLIS, Oct. 10, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea (OSA), today published Inspire V clinical outcomes data from its Singapore clinical study as well as the Company's limited market release in the United States including single site experience at two leading centers. These data will be presented at the American Otolaryngology-Head and Neck Surgery (AAO-HNS) and International Surgical Sleep Society (ISSS) meetings being conducted in Indianapolis between October 9 and October 14....

06.10.25 - 14:03	Inspire Medical Systems, Inc. to Report Third Quarter 2025 Financial Results on November 3, 2025 (GlobeNewswire EN)
	MINNEAPOLIS, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the third quarter 2025 after the close of trading on Monday, November 3. Inspire's management team will host a corresponding conference call beginning at 5:00 p.m. Eastern Time to discuss the financial results and recent business developments....

16.09.25 - 10:27	Nyxoah verklagt nun Inspire Medical Systems wegen Patentverletzung (4investors)
	Um den gesamten Artikel unter 4investors.de zu lesen, klicken Sie bitte auf die Überschrift...

15.09.25 - 22:42	Corporate News: Nyxoah SA. (EQS)
	Nyxoah reicht Klage wegen Patentverletzung gegen Inspire Medical Systems, Inc. ein...

15.09.25 - 22:12	Nyxoah Files Patent Infringement Lawsuit Against Inspire Medical Systems, Inc. (GlobeNewswire EN)
	Nyxoah Files Patent Infringement Lawsuit Against Inspire Medical Systems, Inc....

13.09.25 - 16:06	INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Inspire Medical Systems, Inc. - INSP (PR Newswire)
	NEW YORK, Sept. 13, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Inspire Medical Systems, Inc. ("Inspire" or the "Company") (NYSE: INSP). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The......

08.09.25 - 21:33	INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Inspire Medical Systems, Inc. - INSP (PR Newswire)
	NEW YORK, Sept. 8, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Inspire Medical Systems, Inc. ("Inspire" or the "Company") (NYSE: INSP). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The......

03.09.25 - 03:01	Insiderhandel: Chief Financial Officer verkauft Aktien von Inspire Medical Systems im Wert von 1027290 USD (Insiderkauf)
	Buchholz, Richard - Vorstand - Tag der Transaktion: 2025-08-29...

02.09.25 - 20:30	Where Inspire Medical Systems Stands With Analysts (Benzinga)
	Latest Ratings for INSP DateFirmActionFromTo Feb 2022SVB LeerinkMaintainsOutperform Nov 2021Piper SandlerMaintainsOverweight Nov 2021Wells FargoMaintainsOverweight View More Analyst Ratings for INSP View the Latest Analyst Ratings read more...

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Wer im Krieg tapfer an der Front war, ist im zivilen Leben ein erfolgreicher Verkäufer. - Dr. Fritz P. Rinnhofer

Partner: >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram